A Resource for Healthcare and Social Services Professionals
Attend a free live training event! Browse trainings by topic, month, or event format (virtual or in-person), and then be sure to register online. Please note this list of upcoming trainings is updated regularly. If you do not see a specific training listed below, please check back or email us with any questions. If you want to be notified of newly booked trainings, subscribe to our mailing list.
DEA-eligible
Topic: Harm Reduction
This training reviews strategies for reducing non-communicable infectious diseases in patients that inject drugs. Topics include post-injection techniques, equipment needed for safe injection, and strategies to reduce skin and soft tissue infections (SSTIs). Additional education will be provided on the basics of wound and abscess care to prevent worsening SSTIs.
 |
Thursday, 1/30/2025 4:00 pm – 5:30 pm ET |
 |
This training fulfills the DEA's 8-hour training requirement for prescribers |
 |
Virtual event |
 |
Intended AudienceThe entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction. |
Topic: Harm Reduction
This training teaches strategies for identifying patients experiencing a stimulant overdose and caring for patients experiencing acute psychosis secondary to psychostimulant ingestion. We will focus on warning signs of psychostimulant overdose and strategies to mitigate the harm associated with the patient’s psychotic state, including de-escalation techniques in clinical and community settings.
|
Tuesday, 2/4/2025 3:00 pm – 4:30 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceThe entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction. |
Topic: Harm Reduction
This training explores sexual health-related risks associated with substance use disorder (SUD). We will focus on the impact of survival sex and sex work on the well-being of persons, including strategies to reduce violence and infections in this population. The training will review pharmacological interventions for HIV prevention, including nPEP, PrEP, and the concept of U=U. Participants will be able to define sexually transmitted infection (STI) testing strategies for the SUD provider and treatment considerations for patients on medication for addiction treatment.
|
Thursday, 2/13/2025 4:00 pm – 5:30 pm ET |
|
Virtual event |
|
Intended AudienceThe entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction. |
Topic: Harm Reduction
This training reviews strategies for reducing harm from inhaled and intranasal use of illicit substances. It will discuss strategies for reducing communicable infections and preventing skin and soft tissue infections and lung damage. We will also review the risks associated with open flame and adulterated substances.
|
Tuesday, 2/18/2025 3:00 pm – 4:30 pm ET |
|
Virtual event |
|
Intended AudienceThe entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction. |
Topic: Harm Reduction
This training reviews the impact of alcohol in the U.S., assessing risk-prevention strategies and clinical approaches for reducing alcohol use. We will also define risky alcohol use, binge consumption, and evidence-based treatments and medications for alcohol use disorder.
|
Thursday, 2/27/2025 4:00 pm – 5:30 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceThe entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction. |
Topic: Harm Reduction
This training explores variability in cannabis product potency, including the roles of CBD and THC in differing formulations. We will discuss current research associating cannabis with health outcomes and potential use risks. Further, participants will have opportunities to evaluate strategies for mitigating potential cannabis use-related harms.
|
Tuesday, 3/4/2025 3:00 pm – 4:30 pm ET |
|
Virtual event |
|
Intended AudienceThe entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction. |
Topic: Harm Reduction
This training reviews the basics of overdose education and response, including caring for patients with a history of overdose and the efficacy of bystander overdose education and prevention. We will focus on novel overdose prevention strategies, including test strips, sedation monitoring centers, safe consumption sites, and safe supply. Further, this training identifies naloxone (Narcan's) mechanism of action.
|
Thursday, 3/13/2025 4:00 pm – 5:30 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceThe entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction. |
Topic: Harm Reduction
This training explores the prevalence of substance use in pregnant persons and related risks of use throughout pregnancy, postpartum, and while breastfeeding. We will also focus on interventions to reduce associated harms and engage pregnant and postpartum persons in care without stigma.
|
Tuesday, 3/18/2025 4:00 pm – 5:30 pm ET |
|
Virtual event |
|
Intended AudienceThe entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction. |
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.